XML 53 R41.htm IDEA: XBRL DOCUMENT v3.10.0.1
SEGMENT INFORMATION (Tables)
 9 Months Ended
Jun. 29, 2018
Segment Reporting [Abstract]  
Operating Results Information for Each Business Segment
The following table summarizes select operating results information for each reportable segment:
 
Three Months Ended
 
Nine Months Ended
(In millions)
June 29,
2018
 
June 30,
2017
 
June 29,
2018
 
June 30,
2017
Revenues
 
 
 
 
 
 
 
Oncology Systems
$
667.2

 
$
564.4

 
$
2,014.6

 
$
1,767.5

Varian Particle Therapy
41.9

 
68.4

 
102.9

 
130.0

Total Company
$
709.1

 
$
632.8

 
$
2,117.5

 
$
1,897.5

Operating Earnings
 
 
 
 
 
 
 
Oncology Systems
$
125.6

 
$
104.3

 
$
406.9

 
$
343.3

Varian Particle Therapy
(10.1
)
 
(12.4
)
 
(42.8
)
 
(82.5
)
Total reportable segments
115.5

 
91.9

 
364.1

 
260.8

Unallocated corporate
(24.0
)
 
(3.4
)
 
(56.9
)
 
(64.8
)
Total Company
$
91.5

 
$
88.5

 
$
307.2

 
$
196.0
Schedule of Disaggregation of Revenue
The Company disaggregates its revenues from contracts by major product categories and by geographic region for each of its reportable operating segments, as the Company believes this best depicts how the nature, amount, timing and uncertainty of revenues and cash flows are affected by economic factors. See details in the tables below.
Total Revenues by product type
Three Months Ended
June 29, 2018
 
Nine Months Ended
June 29, 2018
(In millions)
Oncology Systems
 
Varian Particle Therapy
 
Total
 
Oncology Systems
 
Varian Particle Therapy
 
Total
Hardware
$
276.5

 
$
38.1

 
$
314.6

 
$
881.2

 
$
95.5

 
$
976.7

Software (1)
125.1

 
—

 
125.1

 
366.9

 
—

 
366.9

Service
265.6

 
3.8

 
269.4

 
766.5

 
7.4

 
773.9

Total Revenues
$
667.2

 
$
41.9

 
$
709.1

 
$
2,014.6

 
$
102.9

 
$
2,117.5

(1)
Includes software support agreements that are recorded in revenues from service in the Condensed Consolidated Statements of Earnings.
Total Revenues by product type
Three Months Ended
June 30, 2017
 
Nine Months Ended
June 30, 2017
(In millions)
Oncology Systems
 
Varian Particle Therapy
 
Total
 
Oncology Systems
 
Varian Particle Therapy
 
Total
Hardware
$
214.9

 
$
66.5

 
$
281.4

 
$
736.0

 
$
123.4

 
$
859.4

Software (1)
110.4

 
—

 
110.4

 
342.8

 
—

 
342.8

Service
239.1

 
1.9

 
241.0

 
688.7

 
6.6

 
695.3

Total Revenues
$
564.4

 
$
68.4

 
$
632.8

 
$
1,767.5

 
$
130.0

 
$
1,897.5

(1) 
Includes software support agreements that are recorded in revenues from service in the Condensed Consolidated Statements of Earnings.
Total Revenues by geographical region
Three Months Ended
June 29, 2018
 
Nine Months Ended
June 29, 2018
(In millions)
Oncology Systems
 
Varian Particle Therapy
 
Total
 
Oncology Systems
 
Varian Particle Therapy
 
Total
Americas
$
323.2

 
$
19.4

 
$
342.6

 
$
981.8

 
$
57.7

 
$
1,039.5

EMEA
208.5

 
21.2

 
229.7

 
633.2

 
43.3

 
676.5

APAC
135.5

 
1.3

 
136.8

 
399.6

 
1.9

 
401.5

Total Revenues
$
667.2

 
$
41.9

 
$
709.1

 
$
2,014.6

 
$
102.9

 
$
2,117.5

 
 
 
 
 
 
 
 
 
 
 
 
North America
$
298.7

 
$
19.4

 
$
318.1

 
$
924.6

 
$
57.7

 
$
982.3

International
368.5

 
22.5

 
391.0

 
1,090.0

 
45.2

 
1,135.2

Total Revenues
$
667.2

 
$
41.9

 
$
709.1

 
$
2,014.6

 
$
102.9

 
$
2,117.5

Total Revenues by geographical region
Three Months Ended
June 30, 2017
 
Nine Months Ended
June 30, 2017
(In millions)
Oncology Systems
 
Varian Particle Therapy
 
Total
 
Oncology Systems
 
Varian Particle Therapy
 
Total
Americas
$
286.9

 
$
49.4

 
$
336.3

 
$
909.7

 
$
66.4

 
$
976.1

EMEA
157.6

 
11.9

 
169.5

 
494.1

 
44.7

 
538.8

APAC
119.9

 
7.1

 
127.0

 
363.7

 
18.9

 
382.6

Total Revenues
$
564.4

 
$
68.4

 
$
632.8

 
$
1,767.5

 
$
130.0

 
$
1,897.5

 
 
 
 
 
 
 
 
 
 
 
 
North America
$
274.7

 
$
49.4

 
$
324.1

 
$
859.4

 
$
66.4

 
$
925.8

International
289.7

 
19.0

 
308.7

 
908.1

 
63.6

 
971.7

Total Revenues
$
564.4

 
$
68.4

 
$
632.8

 
$
1,767.5

 
$
130.0

 
$
1,897.5

Timing of revenue recognition
Three Months Ended
June 29, 2018
 
Nine Months Ended
June 29, 2018
(In millions)
Products transferred at a point in time
 
Products and Services transferred over time
 
Total
 
Products transferred at a point in time
 
Products and Services transferred over time
 
Total
Oncology Systems
$
326.9

 
$
340.3

 
$
667.2

 
$
1,028.9

 
$
985.7

 
$
2,014.6

Varian Particle Therapy
—

 
41.9

 
41.9

 
—

 
102.9

 
102.9

Total Revenues
$
326.9

 
$
382.2

 
$
709.1

 
$
1,028.9

 
$
1,088.6

 
$
2,117.5

Timing of revenue recognition
Three Months Ended
June 30, 2017
 
Nine Months Ended
June 30, 2017
(In millions)
Products Transferred at a Point in Time
 
Products and Services Transferred Over Time
 
Total
 
Products Transferred at a Point in Time
 
Products and Services Transferred Over Time
 
Total
Oncology Systems
$
253.7

 
$
310.7

 
$
564.4

 
$
870.9

 
$
896.6

 
$
1,767.5

Varian Particle Therapy
—

 
68.4

 
68.4

 
—

 
130.0

 
130.0

Total Revenues
$
253.7

 
$
379.1

 
$
632.8

 
$
870.9

 
$
1,026.6

 
$
1,897.5